Home » Topics » Regulatory » Patents

Patents
RSS

Dopamine agonists from AHP particularly useful in the treatment of schizophrenia

June 8, 1998

Lilly patents nonclassical antifolates for cancer, arthritis and psoriasis

June 8, 1998

Bronchotherapeutic agents in development at Byk Gulden

June 8, 1998

Fujisawa compounds lower blood cholesterol, triglyceride and lipid levels

June 5, 1998

Series of dopamine receptor subtype-selective ligands developed at Pfizer

June 5, 1998

Synthelabo discloses new agents for urinary incontinence

June 5, 1998

Cryptophycins for cancer, fungal infections described in patent literature

June 5, 1998

Novel series of 5-HT1F agonists under study at Lilly

June 5, 1998

Neurokinin antagonists in the pipeline at Schering-Plough

June 4, 1998

Another group of CRF antagonists for stress-related disorders in development at Pfizer

June 4, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...